Pharmaceutical
Biopharmaceutical
Biotechnology
AVEO Pharmaceuticals
$0.609876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$0.60
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.0413 (-6.65%) Today
+$0.0199 (3.43%) After Hours
Why Robinhood?
You can buy or sell AVEO and other stocks, options, ETFs, and crypto commission-free!
About
AVEO Pharmaceuticals, Inc. Common Stock, also called AVEO Pharmaceuticals, is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Read More Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA.
Employees
17
Headquarters
Cambridge, Massachusetts
Founded
2001
Market Cap
73.37M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
2.71M
High Today
$0.6212
Low Today
$0.57
Open Price
$0.615
Volume
1.08M
52 Week High
$3.59
52 Week Low
$0.4906
Collections
Pharmaceutical
Biopharmaceutical
Biotechnology
Health
Technology
Cancer Prevention
Medical
US
News
Markets InsiderMar 21
EQUITY ALERT: Rosen Law Firm Reminds AVEO Pharmaceuticals, Inc. Investors with Over $100K in Losses of Important Deadline in Securities Class Action Lawsuit - AVEO
NEW YORK, March 21, 2019 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of AVEO Pharmaceuticals, Inc.
Guru FocusMar 21
DEADLINE NOTICE: Pawar Law Group Announces a Securities Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. – AVEO
NEW YORK, March 20, 2019 (GLOBE NEWSWIRE) -- Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of AVEO Pharmaceuticals, Inc.
Associated PressMar 15
INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the
This content is a press release from our partner Globe Newswire. The AP newsroom and editorial departments were not involved in its creation. INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm This content is a press release from our partner Globe Newswire. The AP newsroom and editorial departments were not involved in its creation. LOS ANGELES, March 1...
Price Paid on Robinhood
54% Lower
Right Now
52 Week Low
$0.4906
Average Price Paid
$1.29
52 Week High
$3.59
Earnings
-$0.22
-$0.16
-$0.09
-$0.03
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
-$0.06 per share
Actual
-$0.03 per share